Cargando…

Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood Factors

IMPORTANCE: Differences in cerebrospinal fluid (CSF) tau Alzheimer dementia (AD) biomarkers by self-identified race have been observed in prior studies. More recently, plasma biomarkers have been gaining recognition, but whether they exhibit similar differences is unclear. Furthermore, the underlyin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hajjar, Ihab, Yang, Zhiyi, Okafor, Maureen, Liu, Chang, Waligorska, Teresa, Goldstein, Felicia C., Shaw, Leslie M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539715/ https://www.ncbi.nlm.nih.gov/pubmed/36201209 http://dx.doi.org/10.1001/jamanetworkopen.2022.35068

Ejemplares similares

Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment
por: Garrett, Stephanie L., et al.
Publicado: (2019)

Development of digital voice biomarkers and associations with cognition, cerebrospinal biomarkers, and neural representation in early Alzheimer's disease
por: Hajjar, Ihab, et al.
Publicado: (2023)

Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial
por: Hajjar, Ihab, et al.
Publicado: (2020)

Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer’s disease
por: Hajjar, Ihab, et al.
Publicado: (2022)

Neighborhood Disadvantage, Race and Ethnicity, and Postpartum Depression
por: Onyewuenyi, Ticara L., et al.
Publicado: (2023)

Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
por: Nho, Kwangsik, et al.
Publicado: (2019)

Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
por: Erickson, Pontus, et al.
Publicado: (2023)

Neighborhood Disadvantage, African Genetic Ancestry, Cancer Subtype, and Mortality Among Breast Cancer Survivors
por: Iyer, Hari S., et al.
Publicado: (2023)

Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
por: Howell, Jennifer C., et al.
Publicado: (2017)

Association of Neighborhood Resources and Race and Ethnicity With Readmissions for Diabetic Ketoacidosis at US Children’s Hospitals
por: Bergmann, Kelly R., et al.
Publicado: (2022)

Association of Neighborhood-Level Disadvantage With Alzheimer Disease Neuropathology
por: Powell, W. Ryan, et al.
Publicado: (2020)

Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
por: Benedet, Andréa L., et al.
Publicado: (2021)

Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease
por: Higginbotham, Lenora, et al.
Publicado: (2020)

Role of Cerebrospinal Fluid Biomarkers in Clinical Trials for Alzheimer's Disease Modifying Therapies
por: Kang, Ju-Hee, et al.
Publicado: (2014)

APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry
por: Belloy, Michael E., et al.
Publicado: (2023)

Efficient ancestry and mutation simulation with msprime 1.0
por: Baumdicker, Franz, et al.
Publicado: (2021)

Detecting Structure of Haplotypes and Local Ancestry
por: Guan, Yongtao
Publicado: (2014)

Anthropologists' views on race, ancestry, and genetics
por: Wagner, Jennifer K., et al.
Publicado: (2016)

Recurrent mutation in the ancestry of a rare variant
por: Wakeley, John, et al.
Publicado: (2023)

Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid
por: White, Michael D., et al.
Publicado: (2021)

Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease
por: Llibre-Guerra, Jorge J., et al.
Publicado: (2019)

Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers
por: Berger, Miles, et al.
Publicado: (2022)

Association of Rare Coding Mutations With Alzheimer Disease and Other Dementias Among Adults of European Ancestry
por: Patel, Devanshi, et al.
Publicado: (2019)

Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry
por: Blue, Elizabeth E., et al.
Publicado: (2020)

Ancestry Informative Marker Set for Han Chinese Population
por: Qu, Hui-Qi, et al.
Publicado: (2012)

Effects of candesartan on cerebral microvascular function in mild cognitive impairment: Results of two clinical trials
por: Henley, Brandon, et al.
Publicado: (2023)

Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
por: Irwin, David J., et al.
Publicado: (2020)

Association of Cigarette Smoking With Cerebrospinal Fluid Biomarkers of Neurodegeneration, Neuroinflammation, and Oxidation
por: Liu, Yanlong, et al.
Publicado: (2020)

How Comorbidity Reflects on Cerebrospinal Fluid Biomarkers of Neurodegeneration in Aging
por: Zenuni, Henri, et al.
Publicado: (2021)

Race and ancestry in biomedical research: exploring the challenges
por: Caulfield, Timothy, et al.
Publicado: (2009)

Race, ancestry, and genetic risk for kidney failure
por: Nicholas, Susanne B., et al.
Publicado: (2022)

Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer’s disease
por: Shaw, Leslie M., et al.
Publicado: (2018)

Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
por: Czech, Christian, et al.
Publicado: (2012)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Alzheimer disease pathology and the cerebrospinal fluid proteome
por: Dayon, Loïc, et al.
Publicado: (2018)

Cerebrospinal fluid in Alzheimer's: A precious tool
por: Parnetti, Lucilla, et al.
Publicado: (2016)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Comparative Effectiveness of Diversion of Cerebrospinal Fluid for Children With Severe Traumatic Brain Injury
por: Bell, Michael J., et al.
Publicado: (2022)

The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer’s disease
por: Trombetta, Bianca A., et al.
Publicado: (2018)

Association of Stress With Cognitive Function Among Older Black and White US Adults
por: Kulshreshtha, Ambar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m2rl2aqdfsuo3hs8t4v1v6pptd